3122 – SUMOYLATION OF DNMT1 REGULATES RESPONSE TO CATALYTIC INHIBITION OF DNMT1 IN ACUTE MYELOID LEUKAEMIA
Brian Liddicoat(Broad Institute), Mark A. Dawson(The University of Melbourne), Rabinder Prinjha(GlaxoSmithKline (United Kingdom)), Andrew A. Guirguis(Peter MacCallum Cancer Centre), Roland S. Annan(GlaxoSmithKline (United Kingdom)), Michael T. McCabe(GlaxoSmithKline (United States)), Enid Y.N. Lam(The University of Melbourne), Christa van der Maarel(Peter MacCallum Cancer Centre), Naiara Garcia-Bediaga(Peter MacCallum Cancer Centre), Laura Scolamiero(Peter MacCallum Cancer Centre), Ching‐Seng Ang(The University of Melbourne), Melissa B. Pappalardi(GlaxoSmithKline (United States)), Francesca Zappacosta(South College), Andrea Gillespie(National Institutes of Health), Wendy Jia(Peter MacCallum Cancer Centre), Sarah‐Jane Dawson(The University of Melbourne), Laure Talarmain(The University of Melbourne), Cassie Litchfield(Peter MacCallum Cancer Centre), Tao Wang(GlaxoSmithKline (United States)), Andrew B. Das(University of Otago)
Cited by 0
Related Papers
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
|Cancer Cell|2019|630
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
|New England Journal of Medicine|2018|429
Hydrophilic Interaction Chromatography Reduces the Complexity of the Phosphoproteome and Improves Global Phosphopeptide Isolation and Detection
|Molecular & Cellular Proteomics|2008|344